Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology

PURPOSE: Adjuvant chemotherapy within 56 or 84 days following curative resection is globally accepted as the standard of care for stage III colon cancer as it has been associated with improved overall survival. Initiation of adjuvant chemotherapy within this time frame is therefore recommended by cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkrief, Arielle, Redstone, Genevieve, Petruccelli, Luca, Ali, Alla'a, Thomas, Doneal, Fernandez, Myriam, Rousseau, Caroline, Aleynikova, Olga, Anderson, Dawn, Ghitulescu, Gabriela, Vasilevsky, Carol-Ann, Dalfen, Richard, Langleben, Adrian, Liberman, Sender, Kavan, Petr, Alcindor, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942255/
https://www.ncbi.nlm.nih.gov/pubmed/33685857
http://dx.doi.org/10.1136/bmjoq-2020-000934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942255/
https://www.ncbi.nlm.nih.gov/pubmed/33685857
http://dx.doi.org/10.1136/bmjoq-2020-000934

Ejemplares similares